Viking Therapeutics Prices Upsized $500M Dual Capital Raise
Viking Therapeutics priced an upsized $500M capital raise, pairing $275M in common stock at $35 and $225M in 2% convertible senior notes due 2032.
convertible notes
Halozyme Inks $1.5B Convertible Debt Deal and Capped Calls
Halozyme closed a $1.5B convertible debt offering with capped calls, refinancing 2027 and 2028 notes while securing over $630M in fresh liquidity.
CoreWeave Launches $3B Convertible Debt Sale for AI Buildout
CoreWeave announced a $3B Rule 144A convertible senior notes offering due 2033 with capped calls to lower financing costs and fund AI infrastructure capex.
Nebius Group’s $4.5B Convertible Fuels AI Cap-Ex Push
Nebius announced a $4.5 billion two-tranche convertible senior notes offering to fund AI data center buildout after Q2 revenue jumped 454% to $582M.